(Q45163828)

10 December 2017

title

Continuous low-dose chemotherapy plus inhibition of cyclooxygenase-2 as an antiangiogenic therapy of glioblastoma multiforme (English)

1 reference

10 December 2017

1 reference

angiogenesis inhibitor

1 reference

1 reference

1

1 reference

10 December 2017

Rainer Grobholz

2

1 reference

10 December 2017

Tobias Korn

3

1 reference

10 December 2017

Frederik Wenz

4

1 reference

10 December 2017

Ralf Erber

5

1 reference

10 December 2017

Peter Vajkoczy

6

1 reference

10 December 2017

publication date

28 September 2004

1 reference

Journal of Cancer Research and Clinical Oncology

10 December 2017

published in

1 reference

10 December 2017

volume

131

1 reference

10 December 2017

issue

1

1 reference

10 December 2017

page(s)

31-40

1 reference

Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse

10 December 2017

cites work

1 reference

12 December 2020

Therapeutic potential of selective cyclooxygenase-2 inhibitors in the management of tumor angiogenesis

1 reference

12 December 2020

Placental growth factor is a survival factor for tumor endothelial cells and macrophages

1 reference

12 December 2020

Patterns of cyclooxygenase-1 and -2 expression in human gliomas in vivo

1 reference

12 December 2020

Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal

1 reference

12 December 2020

Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials

1 reference

12 December 2020

Fatal allergic vasculitis associated with celecoxib

1 reference

12 December 2020

Thromboxane A2 is a mediator of cyclooxygenase-2-dependent endothelial migration and angiogenesis

1 reference

12 December 2020

Immunolocalization of basic fibroblast growth factor to the microvasculature of human brain tumors

1 reference

12 December 2020

NSAIDs inhibit alpha V beta 3 integrin-mediated and Cdc42/Rac-dependent endothelial-cell spreading, migration and angiogenesis.

1 reference

12 December 2020

Inhibition of glioma angiogenesis and growth in vivo by systemic treatment with a monoclonal antibody against vascular endothelial growth factor receptor-2.

1 reference

12 December 2020

Antiangiogenic agents potentiate cytotoxic cancer therapies against primary and metastatic disease

1 reference

12 December 2020

SU6668 is a potent antiangiogenic and antitumor agent that induces regression of established tumors.

1 reference

12 December 2020

Inhibition of growth of C6 glioma cells in vivo by expression of antisense vascular endothelial growth factor sequence.

1 reference

12 December 2020

Angiogenesis in malignant gliomas

1 reference

12 December 2020

Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria

1 reference

12 December 2020

Computerized tomographic and pathologic studies of the untreated, quiescent, and recurrent glioblastoma multiforme

1 reference

12 December 2020

Prognostic significance of cyclooxygenase-2 pathway and angiogenesis in head and neck squamous cell carcinoma

1 reference

12 December 2020

Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene

1 reference

12 December 2020

Tumor angiogenesis: therapeutic implications

1 reference

12 December 2020

Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing

1 reference

12 December 2020

Neuro-Oncology Working Group 01 trial of nimustine plus teniposide versus nimustine plus cytarabine chemotherapy in addition to involved-field radiotherapy in the first-line treatment of malignant glioma

1 reference

12 December 2020

Differences in therapeutic indexes of combination metronomic chemotherapy and an anti-VEGFR-2 antibody in multidrug-resistant human breast cancer xenografts

1 reference

12 December 2020

Antiproliferative, antiangiogenic and proapoptotic activity of h-R3: A humanized anti-EGFR antibody

1 reference

12 December 2020

Low-dose chemotherapy combined with an antiangiogenic drug reduces human glioma growth in vivo.

1 reference

12 December 2020

Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity

1 reference

12 December 2020

COX-2 inhibitors and cancer therapeutics: potential roles for inhibitors of COX-2 in combination with cytotoxic therapy: reports from a symposium held in conjunction with the Radiation Therapy Oncology Group June 2001 Meeting

1 reference

12 December 2020

Combination of a selective cyclooxygenase-2 inhibitor with epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 and protein kinase A antisense causes cooperative antitumor and antiangiogenic effect.

1 reference

12 December 2020

Inhibition of angiogenesis by non-toxic doses of temozolomide

1 reference

12 December 2020

Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group

1 reference

12 December 2020

Correlation between neovascularisation and neuroendocrine differentiation in prostatic carcinoma

1 reference

12 December 2020

Cyclooxygenase-2 expression in endometrial cancer: correlation with microvessel count and expression of vascular endothelial growth factor and thymidine phosphorylase

1 reference

12 December 2020

Cyclooxygenase-2 inhibitor induces apoptosis and enhances cytotoxicity of various anticancer agents in non-small cell lung cancer cell lines

1 reference

12 December 2020

Protracted low-dose effects on human endothelial cell proliferation and survival in vitro reveal a selective antiangiogenic window for various chemotherapeutic drugs.

1 reference

12 December 2020

Phase I trial of temozolomide using an extended continuous oral schedule.

1 reference

12 December 2020

Inhibition of angiogenesis by the antineoplastic agents mitoxantrone and bisantrene

1 reference

12 December 2020

Selective inhibition of vascular endothelial growth factor-mediated angiogenesis by cyclosporin A: roles of the nuclear factor of activated T cells and cyclooxygenase 2

1 reference

12 December 2020

Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation

1 reference

12 December 2020

Redefining the target: chemotherapeutics as antiangiogenics

1 reference

12 December 2020

Antiangiogenic potential of camptothecin and topotecan

1 reference

12 December 2020

Non steroidal anti-inflammatory drugs and COX-2 inhibitors as anti-cancer therapeutics: hypes, hopes and reality

1 reference

12 December 2020

Preclinical studies of the combination of angiogenic inhibitors with cytotoxic agents

1 reference

12 December 2020

Antitumor effects in mice of low-dose (metronomic) cyclophosphamide administered continuously through the drinking water.

1 reference

12 December 2020

Microvessel density is a prognostic indicator for patients with astroglial brain tumors.

1 reference

12 December 2020

Continuous low-dose anti-angiogenic/ metronomic chemotherapy: from the research laboratory into the oncology clinic

1 reference

12 December 2020

A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse

1 reference

12 December 2020

Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer

1 reference

12 December 2020

Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors

1 reference

12 December 2020

SU6668 inhibits Flk-1/KDR and PDGFRbeta in vivo, resulting in rapid apoptosis of tumor vasculature and tumor regression in mice

1 reference

12 December 2020

Inhibition of tumor growth, angiogenesis, and microcirculation by the novel Flk-1 inhibitor SU5416 as assessed by intravital multi-fluorescence videomicroscopy

1 reference

12 December 2020

Antiangiogenic scheduling of lower dose cancer chemotherapy.

1 reference

12 December 2020

Antiangiogenic therapy in brain tumor models

1 reference

12 December 2020

10.1007/S00432-004-0620-5

Identifiers

DOI

1 reference

10 December 2017

1 reference